Page last updated: 2024-08-23

paclitaxel and ribose

paclitaxel has been researched along with ribose in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Ansell, PJ; Bell-McGuinn, K; Bookman, MA; Coleman, RL; Dinh, MH; Fleming, GF; Friedlander, M; Hosmane, B; Huang, X; Luo, X; Moore, KN; Sehgal, V; Steffensen, KD; Swisher, EM; You, B1
Duarte, D; Nunes, M; Ricardo, S; Vale, N1
Bouberhan, S; Castro, CM; Feghali, L; Gupta, S; Hanna, PE; Katz-Agranov, N; Krasner, CN; Ouyang, T; Sawtell, R; Sise, ME; Wang, Q; Yamada, KS1

Other Studies

3 other study(ies) available for paclitaxel and ribose

ArticleYear
CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023, 01-01, Volume: 41, Issue:1

    Topics: Adenosine Diphosphate; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Ovarian Neoplasms; Paclitaxel; Ribose

2023
Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action.
    Biomolecules, 2022, Oct-16, Volume: 12, Issue:10

    Topics: Adenosine Diphosphate; Antimalarials; Antineoplastic Agents; Artesunate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benztropine; Breast Neoplasms; Cell Line, Tumor; Chloroquine; Colonic Neoplasms; Containment of Biohazards; Doxorubicin; Drug Resistance, Neoplasm; Female; Fluorouracil; Fluoxetine; Fluphenazine; Humans; Ki-67 Antigen; MCF-7 Cells; Michigan; NF-kappa B; Paclitaxel; Poly(ADP-ribose) Polymerase Inhibitors; Ribose; Sertraline; Thioridazine

2022
Kidney function in patients with ovarian cancer treated with poly (ADP-ribose) polymerase (PARP) inhibitors.
    Journal of the National Cancer Institute, 2023, 07-06, Volume: 115, Issue:7

    Topics: Acute Kidney Injury; Carboplatin; Female; Humans; Kidney; Ovarian Neoplasms; Paclitaxel; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Ribose

2023
chemdatabank.com